Distinct modulation of chemokine expression patterns in human monocyte-derived dendritic cells by prostaglandin E2

Cellular Immunology

Volumn 276, Issue 1-2, 2012, Pages 52-58

  Bruckner, Markus ^a   Dickel, Denise ^a   Singer, Eva ^b   Legler, Daniel F ^a  

^a UNIVERSITY OF KONSTANZ   (Switzerland)

^b KLINIKUM KONSTANZ   (Germany)

Author keywords

Chemokines; CTL; FMLP; Human monocyte derived dendritic cells; MoDCs; NK cell

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84863862791     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.03.008     Document Type: Article

References (55)

1. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
2. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
3. Alvarez D., Vollmann E.H., von Andrian U.H. Mechanisms and consequences of dendritic cell migration. Immunity 2008, 29:325-342.
4. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
5. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., Forster R., Burgstahler R., Lipp M., Lanzavecchia A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999, 29:1617-1625.
6. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
7. Piqueras B., Connolly J., Freitas H., Palucka A.K., Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006, 107:2613-2618.
8. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
9. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:3388-3393.
10. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
11. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., Imai T., Yoshie O., Bonecchi R., Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 1998, 161:1083-1086.
12. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998, 188:373-386.
13. Legler D.F., Bruckner M., Uetz-von Allmen E., Krause P. Prostaglandin E(2) at new glance. Novel insights in functional diversity offer therapeutic chances. Int. J. Biochem. Cell Biol. 2010, 42:198-201.
14. Scandella E., Men Y., Gillessen S., Forster R., Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002, 100:1354-1361.
15. Legler D.F., Krause P., Scandella E., Singer E., Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 2006, 176:966-973.
16. Muthuswamy R., Mueller-Berghaus J., Haberkorn U., Reinhart T.A., Schadendorf D., Kalinski P. PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood 2010, 116:1454-1459.
17. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., Narumiya S. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 2003, 9:744-749.
18. Krause P., Bruckner M., Uermosi C., Singer E., Groettrup M., Legler D.F. Prostaglandin E2 enhances T cell proliferation by inducing the co-stimulatory molecules OX40L, CD70 and 4-1BBL on dendritic cells. Blood 2009, 113:2451-2460.
19. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997, 27:3135-3142.
20. Rubio M.T., Means T.K., Chakraverty R., Shaffer J., Fudaba Y., Chittenden M., Luster A.D., Sykes M. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int. Immunol. 2005, 17:1561-1572.
21. Kalinski P., Schuitemaker J.H., Hilkens C.M., Kapsenberg M.L. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998, 161:2804-2809.
22. Khayrullina T., Yen J.H., Jing H., Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 2008, 181:721-735.
23. Sheibanie A.F., Tadmori I., Jing H., Vassiliou E., Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 2004, 18:1318-1320.
24. Muthuswamy R., Urban J., Lee J.J., Reinhart T.A., Bartlett D., Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res. 2008, 68:5972-5978.
25. Jing H., Yen J.H., Ganea D. A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. J. Biol. Chem. 2004, 279:55176-55186.
26. Jing H., Vassiliou E., Ganea D. Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J. Leukoc. Biol. 2003, 74:868-879.
27. Vissers J.L., Hartgers F.C., Lindhout E., Teunissen M.B., Figdor C.G., Adema G.J. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukoc. Biol. 2001, 69:785-793.
28. Kuroda E., Sugiura T., Okada K., Zeki K., Yamashita U. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 2001, 166:1650-1658.
29. Schuler G. Dendritic cells in cancer immunotherapy. Eur. J. Immunol. 2010, 40:2123-2130.
30. Palucka A.K., Ueno H., Fay J.W., Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 2007, 220:129-150.
31. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 2007, 117:1195-1203.
32. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 2007, 7:790-802.
33. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5:296-306.
34. de Vries I.J., Krooshoop D.J., Scharenborg N.M., Lesterhuis W.J., Diepstra J.H., Van Muijen G.N., Strijk S.P., Ruers T.J., Boerman O.C., Oyen W.J., Adema G.J., Punt C.J., Figdor C.G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003, 63:12-17.
35. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., Kirkwood J.M., Storkus W.J., Kalinski P. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 2004, 64:5934-5937.
36. Moller I., Michel K., Frech N., Burger M., Pfeifer D., Frommolt P., Veelken H., Thomas-Kaskel A.K. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application. J. Immunother. 2008, 31:506-519.
37. Krause P., Singer E., Darley P.I., Klebensberger J., Groettrup M., Legler D.F. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell-stimulatory capacity despite IDO. J. Leukoc. Biol. 2007, 82:1106-1114.
38. Castellino F., Huang A.Y., Altan-Bonnet G., Stoll S., Scheinecker C., Germain R.N. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006, 440:890-895.
39. Sallusto F., Kremmer E., Palermo B., Hoy A., Ponath P., Qin S., Forster R., Lipp M., Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 1999, 29:2037-2045.
40. Scimone M.L., Lutzky V.P., Zittermann S.I., Maffia P., Jancic C., Buzzola F., Issekutz A.C., Chuluyan H.E. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005, 114:375-385.
41. Shimaoka T., Nakayama T., Kume N., Takahashi S., Yamaguchi J., Minami M., Hayashida K., Kita T., Ohsumi J., Yoshie O., Yonehara S. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 2003, 171:1647-1651.
42. van der Voort R., Verweij V., de Witte T.M., Lasonder E., Adema G.J., Dolstra H. An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J. Leukoc. Biol. 2010.
43. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., Niu X.D., Chen S.C., Manfra D.J., Wiekowski M.T., Sullivan L.M., Smith S.R., Greenberg H.B., Narula S.K., Lipp M., Lira S.A. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000, 12:495-503.
44. Greaves D.R., Wang W., Dairaghi D.J., Dieu M.C., Saint-Vis B., Franz-Bacon K., Rossi D., Caux C., McClanahan T., Gordon S., Zlotnik A., Schall T.J. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J. Exp. Med. 1997, 186:837-844.
45. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T., Sakaguchi N., Sakaguchi S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 2007, 204:2803-2812.
46. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., D'Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 2001, 194:847-853.
47. McIlroy A., Caron G., Blanchard S., Fremaux I., Duluc D., Delneste Y., Chevailler A., Jeannin P. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. Immunology 2006, 117:507-516.
48. Lebre M.C., Burwell T., Vieira P.L., Lora J., Coyle A.J., Kapsenberg M.L., Clausen B.E., De Jong E.C. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. Immunol. Cell Biol. 2005, 83:525-535.
49. Lim H.W., Lee J., Hillsamer P., Kim C.H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 2008, 180:122-129.
50. Sugimoto Y., Narumiya S. Prostaglandin E receptors. J. Biol. Chem. 2007, 282:11613-11617.
51. Bagorda A., Parent C.A. Eukaryotic chemotaxis at a glance. J. Cell Sci. 2008, 121:2621-2624.
52. Sozzani S., Allavena P., Vecchi A., Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 1999, 66:1-9.
53. Vassiliou E., Jing H., Ganea D. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol. 2003, 223:120-132.
54. Yao C., Sakata D., Esaki Y., Li Y., Matsuoka T., Kuroiwa K., Sugimoto Y., Narumiya S. Prostaglandin E(2)-EP4 signaling promotes immune inflammation through T(H)1 cell differentiation and T(H)17 cell expansion. Nat. Med. 2009, 15:633-640.
55. Martin-Orozco N., Muranski P., Chung Y., Yang X.O., Yamazaki T., Lu S., Hwu P., Restifo N.P., Overwijk W.W., Dong C. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009, 31:787-798.